Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN1F5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,148
Award facts
- Contract value 100% obligated
- $59,148.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $59,148.40 to AmerisourceBergen Drug Corp for the supply of Gardasil 9 syringes (0.5 mL) with an ultimate completion date of January 30, 2026. This non-competitive, firm fixed-price delivery order was issued on January 29, 2026, with performance to be executed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $1 billion through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal medical procurement vendor. The company maintains a robust portfolio of federal contract awards predominantly with the DLA and Defense Health Agency, supplying a comprehensive range of pharmaceutical products including vaccines, specialty medications, and medical devices across multiple therapeutic domains. This delivery order for Gardasil 9 vaccines supports military healthcare operations and is consistent with the company's established role as a primary vendor for federal immunization and pharmaceutical supply needs.
Quick answers
Who was awarded contract SPE2DR26FN1F5?
SPE2DR26FN1F5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FN1F5 worth?
The government has obligated $59,148 on SPE2DR26FN1F5.
Is contract SPE2DR26FN1F5 an order under another contract?
Yes. SPE2DR26FN1F5 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1F5 competed?
The extent of competition for SPE2DR26FN1F5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award